Weight loss shots online usually refer to prescription GLP-1 medications such as semaglutide or tirzepatide, prescribed after a clinician reviews your health history. A legitimate telehealth provider should screen eligibility, explain risks, use licensed pharmacies, and offer follow-up care. Compounded versions may be available but are not FDA-approved.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What are weight loss shots online?
Weight loss shots online are prescription injectable medicines ordered through a telehealth visit, not over-the-counter supplements. The clinician reviews your health history, decides whether a medication is appropriate, and sends a prescription to a licensed pharmacy if you qualify.
Most people asking about weight loss injections mean glucagon-like peptide-1 medicines, often called GLP-1s. These medicines act on hormone pathways that help regulate appetite, fullness, and blood sugar. The FDA-approved semaglutide label describes once-weekly injection use for chronic weight management in adults and certain adolescents who meet label criteria 1.
Prescription injections versus supplements or med-spa products
A prescription injection is different from a supplement, vitamin shot, or no-prescription product sold online. For semaglutide and tirzepatide, the prescribing process should include medical screening, risk counseling, pharmacy review, and follow-up for side effects 1 2.
Brand-name and compounded options patients may encounter
Patients may see Wegovy (semaglutide, a GLP-1 receptor agonist), Ozempic (semaglutide for type 2 diabetes), Zepbound (tirzepatide, a dual GIP/GLP-1 receptor agonist), and Mounjaro (tirzepatide for type 2 diabetes). Some patients also encounter compounded semaglutide via a 503A pharmacy or compounded tirzepatide via a 503A pharmacy. These compounded medications are prescription drugs made for an individual patient when clinically appropriate, but they are not FDA-approved products.
Which weight loss injections can be prescribed online?
Semaglutide and tirzepatide are the main prescription weight loss shots patients ask about online. Whether one is appropriate depends on diagnosis, body mass index, other health conditions, medication history, pregnancy status, contraindications, and clinician judgment.
Semaglutide injection is a GLP-1 receptor agonist. In the STEP 1 trial, adults with overweight or obesity without diabetes received once-weekly semaglutide 2.4 mg plus lifestyle intervention; the active ingredient as studied produced greater mean weight loss than placebo, and individual results varied 5. Common adverse effects in the study and label were mainly gastrointestinal, including nausea, diarrhea, vomiting, and constipation 1 5.
Tirzepatide injection is a dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, often shortened to dual GIP/GLP-1 receptor agonist. In SURMOUNT-1, adults with obesity or overweight without diabetes received once-weekly tirzepatide at study doses of 5 mg, 10 mg, or 15 mg; the active ingredient as studied produced greater mean weight reduction than placebo, and individual results varied 6. The FDA-approved tirzepatide label lists common gastrointestinal side effects and warnings for pancreatitis, gallbladder disease, hypoglycemia when used with certain diabetes drugs, and delayed gastric emptying 2.
| Option | Drug class | Examples patients may see | Key safety notes |
|---|---|---|---|
| Semaglutide | GLP-1 receptor agonist | Wegovy, Ozempic, compounded semaglutide via 503A pharmacy | Nausea, vomiting, diarrhea, constipation; warnings include pancreatitis, gallbladder disease, delayed gastric emptying, and thyroid C-cell tumor warning on FDA-approved labels 1 3 |
| Tirzepatide | Dual GIP/GLP-1 receptor agonist | Zepbound, Mounjaro, compounded tirzepatide via 503A pharmacy | Nausea, vomiting, diarrhea, constipation; warnings include pancreatitis, gallbladder disease, delayed gastric emptying, and thyroid C-cell tumor warning on FDA-approved labels 2 4 |
How does getting weight loss shots online usually work?
Online prescribing should still feel like medical care. A safe process includes an intake, clinician review, prescription only if appropriate, pharmacy fulfillment, and ongoing follow-up.
- 1Complete a health questionnaire or online intake visit. This usually covers height, weight, body mass index, medical history, medications, allergies, pregnancy status, and prior weight loss treatment.
- 2A licensed clinician reviews eligibility. FDA-approved weight management labels use body mass index and weight-related comorbidities as part of the indication, but the final decision is clinical and individualized 1 2.
- 3If appropriate, the clinician sends a prescription to a pharmacy. For compounded medications, the pharmacy should be a state-licensed 503A compounding pharmacy making medication for an identified patient prescription 9.
- 4Follow-up continues after delivery. This matters because nausea, vomiting, diarrhea, constipation, dehydration, gallbladder symptoms, low blood sugar risk with some diabetes drugs, and other issues may require clinician guidance 1 2.
Telehealth rules also matter. Federal policy allows certain prescribing by telemedicine under defined conditions, and clinicians must follow federal and state laws that apply to the patient and prescriber 10.
3-min quiz
Considering online weight loss treatment?
At Chia, you can start with a short online eligibility quiz, then a licensed US provider reviews your health history and prescribes only when clinically appropriate. Chia offers semaglutide injection and tirzepatide tablets or injection, including microdosing plans where clinically appropriate. A prescription is not guaranteed. Compounded medications are not FDA-approved.
Who may qualify for prescription weight loss shots?
Eligibility is based on more than wanting to lose weight. Clinicians look at body mass index, obesity or overweight status, weight-related comorbidities, medical history, current medicines, and safety risks.
The FDA-approved semaglutide and tirzepatide weight management labels include use for adults with obesity, or adults with overweight plus at least one weight-related condition, along with reduced-calorie diet and increased physical activity 1 2. Weight-related comorbidities may include conditions such as hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or type 2 diabetes, depending on the medication label and clinical context 1 2.
Some medical history can affect eligibility. FDA-approved GLP-1 and GIP/GLP-1 labels include contraindications for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 1 2. Clinicians also screen for pancreatitis history, gallbladder disease, kidney problems related to dehydration, severe gastrointestinal disease, diabetes medicines that can cause hypoglycemia, and pregnancy or plans for pregnancy 1 2.
Are online weight loss shots safe?
Safety online depends on the provider, prescription process, and pharmacy source. The safest path is not “online versus in-person”; it is licensed medical review and licensed pharmacy dispensing versus no-prescription or unclear-source products.
Common side effects with semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite 1 2. These effects are often why follow-up matters. Dose changes and whether to continue treatment should be handled by a clinician, not by a fixed internet schedule.
Serious warning symptoms need medical attention. FDA-approved labels warn about pancreatitis symptoms such as severe abdominal pain that may radiate to the back, gallbladder problems, possible kidney injury from dehydration, serious allergic reactions, and delayed gastric emptying that may affect oral medications or anesthesia planning 1 2.
- Red flag: a website sells injections without a prescription.
- Red flag: no licensed clinician reviews your medical history.
- Red flag: the pharmacy name, location, or licensing status is unclear.
- Red flag: the program does not explain side effects, contraindications, or what to do if symptoms occur.
- Red flag: the program promises a specific amount of weight loss. Trial results are averages from studied active ingredients, not guarantees for any person 5 6.
Brand-name versus compounded weight loss shots: what is the difference?
Brand-name and compounded medications can involve the same active ingredient name, but they do not have the same regulatory status. FDA-approved brand-name drugs have FDA-reviewed labeling, manufacturing, and outcomes data for the approved product; compounded drugs are prepared for individual prescriptions and are not FDA-approved 9 11.
| Question | FDA-approved brand-name drug | Compounded medication from a 503A pharmacy |
|---|---|---|
| Regulatory status | FDA-approved for the uses listed in the product label | Not FDA-approved; prepared under compounding rules for an individual patient prescription 9 |
| Examples | Wegovy, Ozempic, Zepbound, Mounjaro | Compounded semaglutide or compounded tirzepatide when prescribed and dispensed by a licensed 503A pharmacy |
| Can they be called the same? | No. Brand-name drugs have specific FDA-approved products and labels. | No. Compounded medications should not be called generic, identical, or equivalent to brand-name drugs. |
| What should matter online? | Clear prescribing criteria, risks, pharmacy source, and follow-up | Clear clinician review, state-licensed 503A pharmacy, transparent ingredients, sterile compounding practices when applicable, and follow-up |
The FDA has warned that compounded versions can carry quality and dosing risks when products come from unclear sources, use unapproved salt forms, or are obtained without appropriate medical oversight 11. For patients, the practical safety question is whether a licensed clinician is guiding care and whether a state-licensed pharmacy is dispensing the prescription.
Weight loss shots online at Chia: semaglutide and tirzepatide options
At Chia, 100% online weight loss care starts with a health questionnaire, then a licensed US provider reviews your information. If treatment is clinically appropriate, medication is prescribed through state-licensed US 503A compounding pharmacies and shipped to your door.
Chia offers semaglutide injection, with plans currently starting at $249/mo. Chia also offers tirzepatide tablets and tirzepatide injection, with tablets currently starting at $249/mo and injections currently starting at $299/mo. Microdosing plans are available for semaglutide and tirzepatide where clinically appropriate, and dosing is provider-guided and adjusted over time.
| Chia option | Forms listed in Chia catalog | Current starting price | Best fit to discuss with a provider |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | Patients looking for a provider-guided GLP-1 injection path |
| Tirzepatide | Tablets and injection | Tablets from $249/mo; injection from $299/mo | Patients discussing a dual GIP/GLP-1 option, including whether tablet or injection format fits their life |
Chia patients can message their care team through the patient portal between visits. That follow-up is important because side effects, medication interactions, tolerability, and goals may change over time.
How much do online weight loss shots cost?
Cost varies by medication, form, pharmacy, dose, supplies, follow-up, and whether a program includes lifestyle or metabolic support. For Chia’s current listed pricing, semaglutide injection plans start at $249/mo, tirzepatide tablets start at $249/mo, and tirzepatide injection starts at $299/mo.
Some patients also ask about multi-treatment protocols. Chia’s Weight + Energy protocol includes NAD+ injection plus a choice of GLP-1 and currently starts at $309/mo. Chia’s Weight + Muscle protocol includes Sermorelin injection plus a choice of GLP-1 and currently starts at $329/mo. These are still prescription paths that require clinician review and are not guaranteed.
- Ask what is included in the monthly price: medication, supplies, clinician follow-up, messaging, and shipping.
- Ask which licensed pharmacy fills the prescription.
- Ask how side effects are handled between visits.
- Ask whether dose changes are clinician-guided.
- Ask how the program explains brand-name versus compounded regulatory status.
What should you ask before choosing an online weight loss injection provider?
Before paying, make sure the program is built around medical care, not just checkout. A real online provider should verify eligibility, explain risks and alternatives, use a licensed pharmacy, and offer follow-up.
- Is a licensed clinician reviewing my full health history before prescribing?
- Which pharmacy fills the prescription, and is it state-licensed?
- Can I contact the care team if I have nausea, vomiting, diarrhea, constipation, abdominal pain, or other side effects?
- Are contraindications discussed, including medullary thyroid carcinoma warning and multiple endocrine neoplasia syndrome type 2?
- Are compounded-drug status, risks, and limits explained clearly?
- Is the program clear that prescriptions are based on medical judgment and are never guaranteed?
Yes, if a licensed clinician reviews your health history and determines that a prescription is clinically appropriate. A legitimate online program should include screening, risk counseling, pharmacy fulfillment, and follow-up.
Yes. Semaglutide and tirzepatide are prescription medications. Any website offering them without a prescription or clinician review is a red flag.
No. Compounded semaglutide should not be described as the same as, generic for, or equivalent to Wegovy or Ozempic. Compounded medications are not FDA-approved, and their outcomes are not FDA-evaluated.
No. Compounded tirzepatide is not the same as, generic for, or equivalent to Zepbound or Mounjaro. Brand-name and compounded products have different regulatory status.
Response varies. Clinical trials of the active ingredients measured weight change over months, not days, and individual results vary. Side effects and tolerability can also affect treatment decisions.
Yes, when prescribed appropriately and dispensed by a licensed pharmacy that ships to your location. At Chia, medications are shipped to the patient’s door when a provider prescribes treatment.
Coverage varies by plan, medication, diagnosis, and pharmacy benefit. Many cash-pay telehealth programs list monthly pricing instead of billing insurance.
You should contact your care team. Nausea, vomiting, diarrhea, constipation, abdominal pain, dehydration symptoms, or symptoms that feel severe need clinician guidance, and urgent symptoms may require emergency care.
3-min quiz
Start with a clinician-reviewed online visit
Chia offers online evaluation for compounded semaglutide injection and compounded tirzepatide tablets or injection, with provider-guided dosing and home delivery from state-licensed US 503A compounding pharmacies when prescribed. A prescription requires medical evaluation and is not guaranteed. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
- 3.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
- 4.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2025.
- 5.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
- 6.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
- 7.American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes. Diabetes Care. 2026.
- 8.Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2015.
- 9.U.S. Food and Drug Administration. Human drug compounding under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. 2024.
- 10.U.S. Drug Enforcement Administration and U.S. Department of Health and Human Services. Third temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. Federal Register. 2024.
- 11.U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
